Using VigiBase to Identify Substandard Medicines: Detection Capacity and Key Prerequisites

BACKGROUND: Substandard medicines, whether the result of intentional manipulation or lack of compliance with good manufacturing practice (GMP) or good distribution practice (GDP), pose a significant potential threat to patient safety. Spontaneous adverse drug reaction reporting systems can contribut...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Drug Saf
Egile Nagusiak: Juhlin, Kristina, Karimi, Ghazaleh, Andér, Maria, Camilli, Sara, Dheda, Mukesh, Har, Tan Siew, Isahak, Rokiah, Lee, Su-Jung, Vaughan, Sarah, Caduff, Pia, Norén, G. Niklas
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer International Publishing 2015
Gaiak:
Original Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4544545/
https://ncbi.nlm.nih.gov/pubmed/25687792
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40264-015-0271-2
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak